Phenylethylamine
•Last Updated: March 30 2023
A trace amine and influencer of many of the 'happy hormones' such as dopamine and serotonin, β-phenylethylamine is an important molecule in the brain with limited supplemental usage due to being rapidly broken down into inactive components.
Phenylethylamine is most often used for
Last Updated: March 30 2023
Note that Phenylethylamine is also known as:
- PEA
- β-phenylethylamine
- phenethylamine
- β-phenethylamine
- Benzeneethanamine
1.^Irsfeld M, Spadafore M, Prüß BMβ-phenylethylamine, a small molecule with a large impactWebmedcentral.(2013 Sep 30)
2.^Premont RT1, Gainetdinov RR, Caron MGFollowing the trace of elusive aminesProc Natl Acad Sci U S A.(2001 Aug 14)
4.^Kim B1, Byun BY, Mah JHBiogenic amine formation and bacterial contribution in Natto productsFood Chem.(2012 Dec 1)
5.^Figueiredo TC1, Viegas RP, Lara LJ, Baião NC, Souza MR, Heneine LG, Cançado SVBioactive amines and internal quality of commercial eggsPoult Sci.(2013 May)
6.^Granvogl M1, Bugan S, Schieberle PFormation of amines and aldehydes from parent amino acids during thermal processing of cocoa and model systems: new insights into pathways of the strecker reactionJ Agric Food Chem.(2006 Mar 8)
7.^Janssen PA1, Leysen JE, Megens AA, Awouters FHDoes phenylethylamine act as an endogenous amphetamine in some patientsInt J Neuropsychopharmacol.(1999 Sep)
8.^Flydal MI1, Martinez APhenylalanine hydroxylase: function, structure, and regulationIUBMB Life.(2013 Apr)
10.^Paterson IA1, Juorio AV, Boulton AA2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous systemJ Neurochem.(1990 Dec)
11.^Guldberg P1, Güttler FMutations in the phenylalanine hydroxylase gene: methods for their characterizationActa Paediatr Suppl.(1994 Dec)
12.^Eisensmith RC1, Martinez DR, Kuzmin AI, Goltsov AA, Brown A, Singh R, Elsas LJ II, Woo SLMolecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US populationPediatrics.(1996 Apr)
13.^CAMP BJ, LYMAN CMThe isolation of N-methyl beta-phenylethylamine from Acacia berlandieriJ Am Pharm Assoc Am Pharm Assoc (Baltim).(1956 Nov)
14.^Adams HR, Camp BJThe isolation and identification of three alkaloids from Acacia BerlandieriToxicon.(1966 Aug)
15.^Shannon HE, Cone EJ, Yousefnejad DPhysiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dogJ Pharmacol Exp Ther.(1982 Oct)
16.^Lindemann L1, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MCTrace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptorsGenomics.(2005 Mar)
17.^Reese EA1, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DKTrace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamineJ Pharmacol Exp Ther.(2007 Apr)
18.^Borowsky B1, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald CTrace amines: identification of a family of mammalian G protein-coupled receptorsProc Natl Acad Sci U S A.(2001 Jul 31)
19.^Wainscott DB1, Little SP, Yin T, Tu Y, Rocco VP, He JX, Nelson DLPharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1J Pharmacol Exp Ther.(2007 Jan)
20.^Miller GM1, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BKPrimate trace amine receptor 1 modulation by the dopamine transporterJ Pharmacol Exp Ther.(2005 Jun)
21.^Bunzow JR1, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DKAmphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptorMol Pharmacol.(2001 Dec)
22.^Xie Z1, Vallender EJ, Yu N, Kirstein SL, Yang H, Bahn ME, Westmoreland SV, Miller GMCloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic associationJ Neurosci Res.(2008 Nov 15)
23.^Barak LS1, Salahpour A, Zhang X, Masri B, Sotnikova TD, Ramsey AJ, Violin JD, Lefkowitz RJ, Caron MG, Gainetdinov RRPharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensorMol Pharmacol.(2008 Sep)
24.^Miller GMThe emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activityJ Neurochem.(2011 Jan)
25.^Babusyte A1, Kotthoff M, Fiedler J, Krautwurst DBiogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2J Leukoc Biol.(2013 Mar)
26.^Kleinau G1, Pratzka J, Nürnberg D, Grüters A, Führer-Sakel D, Krude H, Köhrle J, Schöneberg T, Biebermann HDifferential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonistsPLoS One.(2011)
27.^Wallach JVEndogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perceptionMed Hypotheses.(2009 Jan)
28.^Xie Z1, Miller GMBeta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brainJ Pharmacol Exp Ther.(2008 May)
29.^Hjorth S1, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SBSerotonin autoreceptor function and antidepressant drug actionJ Psychopharmacol.(2000 Jun)
30.^Garcia AS1, Barrera G, Burke TF, Ma S, Hensler JG, Morilak DAAutoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatmentJ Neurochem.(2004 Nov)
31.^Durden DA, Philips SR, Boulton AAIdentification and distribution of beta-phenylethylamine in the ratCan J Biochem.(1973 Jul)
33.^Saavedra JMEnzymatic isotopic assay for and presence of beta-phenylethylamine in brainJ Neurochem.(1974 Feb)
34.^Mosnaim AD1, Callaghan OH, Hudzik T, Wolf MERat brain-uptake index for phenylethylamine and various monomethylated derivativesNeurochem Res.(2013 Apr)
35.^Oldendorf WHBrain uptake of radiolabeled amino acids, amines, and hexoses after arterial injectionAm J Physiol.(1971 Dec)
36.^Hossain M1, Wickramasekara RN, Carvelli Lβ-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neuronsNeurochem Int.(2013 Oct 23)
37.^Yang HY, Neff NHBeta-phenylethylamine: a specific substrate for type B monoamine oxidase of brainJ Pharmacol Exp Ther.(1973 Nov)
38.^Suzuki O, Katsumata Y, Oya MOxidation of beta-phenylethylamine by both types of monoamine oxidase: examination of enzymes in brain and liver mitochondria of eight speciesJ Neurochem.(1981 Mar)
39.^Roth JA, Gillis CNDeamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramineBiochem Pharmacol.(1974 Sep 15)
40.^Paterson IAThe potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenalineNeurochem Res.(1993 Dec)
41.^Suzuki O, Oya M, Katsumata YCharacterization of N-methylphenylethylamine and N-methylphenylethanolamine as substrates for type A and type B monoamine oxidaseBiochem Pharmacol.(1980 Oct 1)
42.^Saavedra JM, Axelrod JDemonstration and distribution of phenylethanolamine in brain and other tissuesProc Natl Acad Sci U S A.(1973 Mar)
43.^Ziegler MG1, Bao X, Kennedy BP, Joyner A, Enns RLocation, development, control, and function of extraadrenal phenylethanolamine N-methyltransferaseAnn N Y Acad Sci.(2002 Oct)
44.^Wu Q1, McLeish MJKinetic and pH studies on human phenylethanolamine N-methyltransferaseArch Biochem Biophys.(2013 Nov 1)
45.^Suzuki O, Katsumata Y, Oya M, Matsumoto TOxidation of phenylethanolamine and octopamine by type A and type B monoamine oxidase. Effect of substrate concentrationBiochem Pharmacol.(1979 Aug 1)
46.^Edwards DJPhenylethanolamine is a specific substrate for type B monoamine oxidaseLife Sci.(1978 Sep 18)
47.^Levitt P, Pintar JE, Breakefield XOImmunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neuronsProc Natl Acad Sci U S A.(1982 Oct)
48.^Ma G1, Bavadekar SA, Schaneberg BT, Khan IA, Feller DREffects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypesPlanta Med.(2010 Jul)
49.^Barroso N1, Rodriguez MAction of beta-phenylethylamine and related amines on nigrostriatal dopamine neurotransmissionEur J Pharmacol.(1996 Feb 22)
50.^Sotnikova TD1, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RRDopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamineJ Neurochem.(2004 Oct)
51.^Bailey BA, Philips SR, Boulton AAIn vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamineNeurochem Res.(1987 Feb)
52.^Ishida K1, Murata M, Katagiri N, Ishikawa M, Abe K, Kato M, Utsunomiya I, Taguchi KEffects of beta-phenylethylamine on dopaminergic neurons of the ventral tegmental area in the rat: a combined electrophysiological and microdialysis studyJ Pharmacol Exp Ther.(2005 Aug)
53.^Liang NY, Rutledge COEvidence for carrier-mediated efflux of dopamine from corpus striatumBiochem Pharmacol.(1982 Aug 1)
54.^Raiteri M, Bertollini A, del Carmine R, Levi GEffects of phenethylamine derivatives on the release of biogenic amines from synaptosomesBiochem Soc Trans.(1976)
55.^Rodriguez M1, Barroso Nbeta-Phenylethylamine regulation of dopaminergic nigrostriatal cell activityBrain Res.(1995 Dec 12)
56.^Mercuri NB1, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernardi G, Borrelli ELoss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient miceNeuroscience.(1997 Jul)
57.^Nakamura M1, Ishii A, Nakahara DCharacterization of beta-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis studyEur J Pharmacol.(1998 May 22)
58.^Negus SS1, Mello NKEffects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeysPsychopharmacology (Berl).(2003 May)
59.^Grabowski J1, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FGDextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trialJ Clin Psychopharmacol.(2001 Oct)
60.^Daw ND1, Kakade S, Dayan POpponent interactions between serotonin and dopamineNeural Netw.(2002 Jun-Jul)
61.^Rothman RB1, Baumann MHBalance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsAnn N Y Acad Sci.(2006 Aug)
62.^Rothman RB1, Blough BE, Baumann MHDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsAAPS J.(2007 Jan 5)
63.^Rothman RB1, Blough BE, Baumann MHDopamine/serotonin releasers as medications for stimulant addictionsProg Brain Res.(2008)
64.^Ekkekakis P1, Petruzzello SJAcute aerobic exercise and affect: current status, problems and prospects regarding dose-responseSports Med.(1999 Nov)
65.^Szabo A1, Billett E, Turner JPhenylethylamine, a possible link to the antidepressant effects of exerciseBr J Sports Med.(2001 Oct)
66.^Nelson DA1, Tolbert MD, Singh SJ, Bost KLExpression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytesJ Neuroimmunol.(2007 Dec)
67.^D'Andrea G1, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon AHPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytesNeurosci Lett.(2003 Jul 31)
68.^Lynnes T1, Horne SM, Prüß BMß-Phenylethylamine as a novel nutrient treatment to reduce bacterial contamination due to Escherichia coli O157:H7 on beef meatMeat Sci.(2014 Jan)
69.^Becú-Villalobos D1, Thyssen SM, Rey EB, Lux-Lantos V, Libertun COctopamine and phenylethylamine inhibit prolactin secretion both in vivo and in vitroProc Soc Exp Biol Med.(1992 Feb)
70.^Becú-Villalobos D, Vacas MI, Libertun CProlactin inhibition by p-tyramine in the male rat: site of actionEndocrinology.(1987 Jun)
72.^Sterling NW1, Du G, Lewis MM, Dimaio C, Kong L, Eslinger PJ, Styner M, Huang XStriatal shape in Parkinson's diseaseNeurobiol Aging.(2013 Nov)
73.^Dyck LE, Yang CR, Boulton AAThe biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slicesJ Neurosci Res.(1983)
74.^Juorio AV1, Paterson IA, Zhu MY, Matte GElectrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatumJ Neurochem.(1991 Jan)
75.^Zhou G1, Shoji H, Yamada S, Matsuishi TDecreased beta-phenylethylamine in CSF in Parkinson's diseaseJ Neurol Neurosurg Psychiatry.(1997 Dec)
77.^Cashin CHEffect of sympathomimetic drugs in eliciting hypertensive responses to reserpine in the rat, after pretreatment with monoamineoxidase inhibitorsBr J Pharmacol.(1972 Feb)
78.^Finberg JP1, Gillman KSelective inhibitors of monoamine oxidase type B and the "cheese effect"Int Rev Neurobiol.(2011)
79.^Wimbiscus M1, Kostenko O, Malone DMAO inhibitors: risks, benefits, and loreCleve Clin J Med.(2010 Dec)
80.^Johnson LA1, Furman CA, Zhang M, Guptaroy B, Gnegy MERapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulationNeuropharmacology.(2005 Nov)
81.^Furman CA1, Chen R, Guptaroy B, Zhang M, Holz RW, Gnegy MDopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopyJ Neurosci.(2009 Mar 11)
82.^Saunders C1, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli AAmphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanismProc Natl Acad Sci U S A.(2000 Jun 6)
83.^Fleckenstein AE1, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GRDifferential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter functionEur J Pharmacol.(1999 Oct 1)
84.^Gulley JM1, Doolen S, Zahniser NRBrief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivoJ Neurochem.(2002 Oct)
Primary Use
Secondary Use